Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986154 · ClinicalTrials.gov registry record · Phase 3
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
A Phase 3 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 3
- Development phase
- 8,292
- Enrollment target
NCT00986154: Completed Phase 3 study, sponsored by Daiichi Sankyo.
NCT00986154 is a Phase 3 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 8,292 participants, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (975% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00986154, a Phase 3 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 8,292 participants
- Enrollment target
Study Summary
Evaluation of heparin/edoxaban tosylate (DU176b) versus heparin/warfarin in preventing recurrence of blood clots in patients with acute symptomatic deep-vein blood clots in the legs and/or blood clots in the lungs.
Primary Outcome
Symptomatic recurrent Venous Thromboembolism (VTE), i.e., the composite of deep Vein Thrombosis (DVT), non-fatal Pulmonary Embolism (PE), and fatal PE occurring during the Overall Study Period. Overall Study Period defined as "The time from the reference date (randomization date/initial dose of study drug date) to the last study follow-up visit."
Interventions
- DRUG warfarin
- DRUG edoxaban tosylate(DU-176b)
- DRUG low molecular weight heparin/unfractionated heparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,292 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-04 |
| Phase | Phase 3 |
What the finished NCT00986154 record still lists
NCT00986154 is an interventional study that assigns participants to a tested intervention. Its 8,292 participants enrollment target places it among the larger protocols in the corpus, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (975% higher).
The record links to 0 conditions, and to 3 interventions - of which warfarin is the first listed.
NCT00986154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00986154 about?
NCT00986154 is a clinical study titled "Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).". Evaluation of heparin/edoxaban tosylate (DU176b) versus heparin/warfarin in preventing recurrence of blood clots in patients with acute symptomatic deep-vein blood clots in the legs and/or blood clots in the lungs.
What is the current status of trial NCT00986154?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 8,292 participants. The study started on 2009-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00986154?
The interventions under investigation include: warfarin (DRUG), edoxaban tosylate(DU-176b) (DRUG), low molecular weight heparin/unfractionated heparin (DRUG).
Who is sponsoring clinical trial NCT00986154?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00986154's enrollment target sits among peer trials
8,292 32nd of 2000 higher than 1,969 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07185828 · 8,286 participants · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
- NCT06435806 · 8,200 participants · NA
Medical Illustration Design Characteristic Evaluation
- NCT06184945 · 8,100 participants · NA
Behavioral Economic & Staffing Strategies in the ICU
- NCT05593484 · 8,060 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia